Austar Lifesciences Limited
AULSF
$0.07
$0.0651,300.00%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 114.03% | 56.93% | -2,231.76% | -313.02% | -228.02% |
| Total Depreciation and Amortization | 18.19% | 27.93% | 25.49% | 21.01% | 16.28% |
| Total Amortization of Deferred Charges | 2.59% | 16.08% | 31.76% | 53.19% | 83.59% |
| Total Other Non-Cash Items | -95.98% | -30.26% | 90.92% | 184.59% | 732.94% |
| Change in Net Operating Assets | 119.36% | 69.47% | -21.46% | -21.46% | -21.46% |
| Cash from Operations | 251.79% | 196.83% | 136.46% | 56.77% | -65.73% |
| Capital Expenditure | 70.86% | 54.04% | 36.66% | 39.61% | 41.53% |
| Sale of Property, Plant, and Equipment | 1,018.80% | 3,101.60% | 4,471.69% | 3,777.09% | 247.22% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 34.46% | 299.13% | 134.59% | 137.86% | 140.94% |
| Cash from Investing | 107.92% | 91.64% | 82.48% | 71.40% | 64.73% |
| Total Debt Issued | -31.47% | -14.39% | -17.81% | 16.58% | 79.18% |
| Total Debt Repaid | -42.61% | -49.44% | -52.27% | -79.87% | -133.49% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 28.06% | 24.01% | 86.29% | 67.82% | -352.76% |
| Cash from Financing | -167.54% | -137.17% | -91.53% | -31.19% | 16.17% |
| Foreign Exchange rate Adjustments | 677.23% | 3.34% | -71.92% | -77.24% | -84.71% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -89.34% | 182.37% | 126.69% | 136.94% | 144.87% |